Biomaterials.info

powered by FreeFind

US Food and Drug Administration (FDA) - Inactive Ingredients

FDA Inactive Ingredients - Updated May 2006

What is the purpose of the Inactive Ingredients Database?

The Inactive Ingredients Database provides information on inactive ingredients present in FDA-approved drug products. This information can be used by industry as an aid in developing drug products. For new drug development purposes, once an inactive ingredient has appeared in an approved drug product for a particular route of administration, the inactive ingredient is not considered new and may require a less extensive review the next time it is included in a new drug product. For example, if a particular inactive ingredient has been approved in a certain dosage form at a certain potency, a sponsor could consider it safe for use in a similar manner for a similar type of product.
FDA Devices
FDA Inactive Ingredients
FDA Inactive Ingredients
FDA Inactive Ingredients


First Page Previous Page Next Page Last Page
Inactive Ingredient Route / Dosage Form
CORN OIL INTRAMUSCULAR; INJECTION
CORN OIL ORAL; CAPSULE
CORN OIL ORAL; CAPSULE, SOFT GELATIN
CORN OIL ORAL; SUSPENSION
CORN OIL ORAL; TABLET
CORN OIL ORAL; TABLET, COATED
CORN OIL ORAL; TABLET, DELAYED ACTION, ENTERIC COATED
CORN OIL SUBLINGUAL; TABLET
CORN OIL PEG-6 ESTERS ORAL; CAPSULE, SOFT GELATIN
CORN SYRUP ORAL; SOLUTION
CORN SYRUP ORAL; SOLUTION, ELIXIR
CORN SYRUP ORAL; SUSPENSION
CORN SYRUP ORAL; SUSPENSION, LIQUID
CORN SYRUP ORAL; SUSPENSION, SUSTAINED ACTION
CORN SYRUP ORAL; SYRUP
CORN SYRUP ORAL; TABLET
CORN SYRUP ORAL; TABLET, UNCOATED, TROCHE
COTTONSEED OIL INTRAMUSCULAR; INJECTION
COTTONSEED OIL ORAL; CAPSULE, SOFT GELATIN
COTTONSEED OIL, HYDROGENATED ORAL; CAPSULE
COTTONSEED OIL, HYDROGENATED ORAL; CAPSULE, SUSTAINED ACTION
COTTONSEED OIL, HYDROGENATED ORAL; TABLET
COTTONSEED OIL, HYDROGENATED ORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE
COTTONSEED OIL, HYDROGENATED ORAL; TABLET, COATED
COTTONSEED OIL, HYDROGENATED ORAL; TABLET, DELAYED ACTION, ENTERIC COATED
COTTONSEED OIL, HYDROGENATED ORAL; TABLET, SUSTAINED ACTION
COTTONSEED OIL, HYDROGENATED SUBLINGUAL; TABLET
CREAM BASE TOPICAL; EMULSION, CREAM
CREATINE INTRA-ARTICULAR; INJECTION
CREATINE INTRALESIONAL; INJECTION
CREATINE INTRAMUSCULAR; INJECTION
CREATININE AURICULAR (OTIC); SOLUTION
CREATININE IM - IV - SC; INJECTION
CREATININE IM - IV; INJECTION
CREATININE INTRA-ARTICULAR; INJECTION
CREATININE INTRA-ARTICULAR; INJECTION, SUSTAINED ACTION
CREATININE INTRABURSAL; INJECTION
CREATININE INTRADERMAL; INJECTION, SUSTAINED ACTION
CREATININE INTRALESIONAL; INJECTION
CREATININE INTRALESIONAL; INJECTION, SUSTAINED ACTION
CREATININE INTRAMUSCULAR; INJECTION
CREATININE INTRAMUSCULAR; INJECTION, SUSTAINED ACTION
CREATININE INTRASYNOVIAL; INJECTION
CREATININE INTRASYNOVIAL; INJECTION, SUSTAINED ACTION
CREATININE OPHTHALMIC; SOLUTION
CREATININE OPHTHALMIC; SOLUTION, DROPS
CREATININE SOFT TISSUE; INJECTION
CREATININE TOPICAL; EMULSION, CREAM
CRESOL SUBCUTANEOUS; INJECTION
CRESOL, M- IM - IV - SC; INJECTION
CRESOL, M- IM - SC; INJECTION
CRESOL, M- INTRADERMAL; INJECTION
CRESOL, M- INTRAMUSCULAR; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED
CRESOL, M- IV(INFUSION); INJECTION
CRESOL, M- SUBCUTANEOUS; INJECTABLE
CRESOL, M- SUBCUTANEOUS; INJECTION
CRESOL, M- SUBCUTANEOUS; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED
CRESOL, M- SUBCUTANEOUS; SOLUTION, INJECTION
CRESOL, M- SUBCUTANEOUS; SUSPENSION, INJECTION
CROSCARMELLOSE SODIUM INTRAMUSCULAR; INJECTION
CROSCARMELLOSE SODIUM ORAL; CAPSULE
CROSCARMELLOSE SODIUM ORAL; CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN
CROSCARMELLOSE SODIUM ORAL; CAPSULE, ENTERIC COATED PELLETS
CROSCARMELLOSE SODIUM ORAL; CAPSULE, HARD GELATIN
CROSCARMELLOSE SODIUM ORAL; GRANULE, FOR RECONSTITUTION
CROSCARMELLOSE SODIUM ORAL; GRANULE, FOR SUSPENSION
CROSCARMELLOSE SODIUM ORAL; SOLUTION
CROSCARMELLOSE SODIUM ORAL; TABLET
CROSCARMELLOSE SODIUM ORAL; TABLET (IMMED./COMP. RELEASE), FILM COATED
CROSCARMELLOSE SODIUM ORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE
CROSCARMELLOSE SODIUM ORAL; TABLET, COATED
CROSCARMELLOSE SODIUM ORAL; TABLET, DELAYED ACTION
CROSCARMELLOSE SODIUM ORAL; TABLET, DELAYED ACTION, ENTERIC COATED
CROSCARMELLOSE SODIUM ORAL; TABLET, FILM COATED
CROSCARMELLOSE SODIUM ORAL; TABLET, ORALLY DISINTEGRATING
CROSCARMELLOSE SODIUM ORAL; TABLET, SUGAR COATED
CROSCARMELLOSE SODIUM ORAL; TABLET, SUSTAINED ACTION
CROSCARMELLOSE SODIUM ORAL; TABLET, UNCOATED, TROCHE
CROSCARMELLOSE SODIUM ORAL-21; TABLET
CROSCARMELLOSE SODIUM ORAL-28; TABLET
CROSCARMELLOSE SODIUM ORAL-28; TABLET, COATED
CROSCARMELLOSE SODIUM SUBLINGUAL; TABLET
CROSPOVIDONE IMPLANTATION; PELLET
CROSPOVIDONE INTRA-ARTICULAR; INJECTION
CROSPOVIDONE INTRAMUSCULAR; INJECTION
CROSPOVIDONE INTRAUTERINE; SOLUTION
CROSPOVIDONE ORAL; CAPSULE
CROSPOVIDONE ORAL; CAPSULE, COATED, SOFT GELATIN
CROSPOVIDONE ORAL; CAPSULE, ENTERIC COATED PELLETS
CROSPOVIDONE ORAL; CAPSULE, HARD GELATIN
CROSPOVIDONE ORAL; CAPSULE, SUSTAINED ACTION
CROSPOVIDONE ORAL; DISPERSIBLE TABLET
CROSPOVIDONE ORAL; MUCILAGE
CROSPOVIDONE ORAL; POWDER, FOR SUSPENSION
CROSPOVIDONE ORAL; SUSPENSION
CROSPOVIDONE ORAL; SUSPENSION, SUSTAINED ACTION
CROSPOVIDONE ORAL; TABLET
CROSPOVIDONE ORAL; TABLET (IMMED./COMP. RELEASE), FILM COATED
CROSPOVIDONE ORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE
CROSPOVIDONE ORAL; TABLET, COATED

First Page Previous Page Next Page Last Page




Last Modified: 29 April 2006
http://www.biomaterials.info
Sitemap
Link | Link | Link | Link | Link | Link | Link | Link